TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said he would not be surprised if Allergan (AGN - Get Report) looked at buying Anacor (ANAC) before Pfizer (PFE - Get Report) decided to acquire the company for $5.2 billion, including debt. Cramer said, 'the area of atopic dermatitis is a crowded field. I think people have to recognize that Pfizer may have decided that we have to buy someone. This is a very unusual acquisition because Pfizer has been building up its cancer franchise.'
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
Can You Name the Companies Behind These Clever Stock Tickers?
How well do you know your favorite companies? Watch the video and play #StreetTrivia.
Trump Economy to Be Scrutinized in Democratic Debates
The Democrats are gearing up to debate each other, but the president's economic agenda will be under scrutiny.
The U.S. Is Producing Less Than 1% of its Uranium, That Should Shock People
Mark Chalmers, CEO of Energy Fuels Resources, zeroes in on why it's shocking that the U.S. is producing less than 1% of its Uranium.
How Millennials Are Shaking Up the Grocery Industry
Grocery Outlet's CEO gives an inside look at how the company is attracting millennials.
FedEx, Micron, Lennar Earnings: What Investors Should Watch For
Here's what investors should look for FedEx's, Micron's, Lennar's earnings reports, according to Jim Cramer's Action Alerts PLUS' team.